Explore our database of over 4000 laboratory markers.
Search and Understand 4000+ Biomarkers
Optimal range: 3.7 - 18.1 µmol/L
Eicosenoic acid has recently been reported as one of the five biomarkers for diagnosis of schizophrenia.
Optimal range: 1.3 - 4.1 micromol/24 hr
11-Hydroxy-androsterone is a that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 71 - 496 nmol/dL (SG)
11-Hydroxy-androsterone is a 5β-reduced compound that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 43 - 391 nmol/dL (SG)
11-Hydroxy-androsterone is a 5β-reduced compound that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 210 - 920 ng/mg Creat/Day
11-Hydroxy-Androsterone (OHAN) is a urinary metabolite of cortisol metabolism as well as 11-oxygenated androgens production from the adrenal glands. While research is limited in the significance of elevations of this metabolite, it may be associated with certain conditions like 21-hydroxylase deficiency and castration- resistant prostate cancer.
Optimal range: 180 - 800 ng/mg Creat/Day
OHAN is a urinary metabolite of cortisol metabolism as well as 11-oxygenated androgens production from the adrenal glands.
Optimal range: 250 - 1000 ng/mg Creat/Day
LEARN MOREOptimal range: 0.5 - 2.6 micromol/24 hr
11-Hydroxy-etiocholanolone is a compound that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 64 - 363 nmol/dL (SG)
11-Hydroxy-etiocholanolone is a compound that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 49 - 336 nmol/dL (SG)
11-Hydroxy-etiocholanolone is a compound that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 35 - 380 ng/mg Creat
LEARN MOREOptimal range: 40 - 470 ng/mg Creat/Day
OHET is the product of cortisol metabolism as well as 11-oxygenated androgens produced from the adrenal gland. Levels tend to reflect levels of etiocholanolone.
Optimal range: 20 - 710 ng/mg Creat/Day
LEARN MOREOptimal range: 0.3 - 1.9 micromol/24 hr
11-Keto-androsterone is a that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 37 - 236 nmol/dL (SG)
11-Keto-androsterone is a that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 46 - 258 nmol/dL (SG)
11-Keto-androsterone is a that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 0.3 - 1.6 micromol/24 hr
11-Keto-etiocholanolone is a compound that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 57 - 315 nmol/dL (SG)
11-Keto-etiocholanolone is a 5β-reduced compound that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
Optimal range: 0 - 0 nmol/dL (SG)
11-Keto-etiocholanolone is a 5β-reduced compound that is an end product of androgen catabolism.
In the Genova complete hormone test this marker is part of the "Total 17-ketosteroids" group.
Androgens are important hormones in the health of both men and women. Testosterone and DHEA are metabolized into what is collectively known as the 17-ketosteroids (DHEA is formally included as a 17-ketosteroid). Together, these markers provide a comprehensive assessment of androgen sufficiency, as well as evaluating the need for, and monitoring of, androgen hormone therapy.
